Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Zanaboni

Showing results (11-20 of 47) with videos related to

Pageof 5
Sort By:
Acta Obstetricia Et Gynecologica Scandinavica|October 1, 1995
Diagnosis of pelvic masses with transabdominal color Doppler, CA 125 and ultrasonographyM Franchi, P Beretta, F Ghezzi, et al.
Gynecologic Oncology|October 1, 1991
Salvage chemotherapy for ovarian cancer recurrence: weekly cisplatin in combination with epirubicin or etoposideF Zanaboni, G Scarfone, M Presti, et al.
Gynecologic Oncology|September 1, 1987
Tumor antigen CA 125 as a marker of ovarian epithelial carcinomaF Zanaboni, F Vergadoro, M Presti, et al.
Obstetrics and Gynecology|June 11, 1999
Endometrial thickness in tamoxifen-treated patients: an independent predictor of endometrial diseaseM Franchi, F Ghezzi, N Donadello, et al.
Obstetrics and Gynecology|November 5, 1997
Nonclosure of peritoneum at radical abdominal hysterectomy and pelvic node dissection: a randomized studyM Franchi, F Ghezzi, F Zanaboni, et al.
The Journal of the American Association of Gynecologic Laparoscopists|May 1, 1995
Management of adnexal masses by operative laparoscopyB van Herendael, P Beretta, T Slangen, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 19, 2000
A phase II study of high-dose epirubicin in ovarian cancer patients previously treated with cisplatin. EORTC Gynecological Cancer Cooperative GroupJ B Vermorken, A Kobierska, B Chevallier, et al.
European Journal of Cancer (Oxford, England : 1990)|January 30, 2004
'State of the art' of radical hysterectomy; current practice in European oncology centresJ B Trimbos, M Franchi, F Zanaboni, et al.
British Journal of Cancer|January 1, 1986
Evaluation of the interaction of mononuclear phagocytes with ovarian carcinoma cells in a colony assayG Peri, F Zanaboni, S Rossini, et al.
Tumori|February 29, 1988
Analysis of 309 cases after hydatidiform mole: different follow-up program according to biologic behaviorG Bolis, C Belloni, C Bonazzi, et al.
Pageof 5

Showing results (11-20 of 47) with videos related to

Sort By:
Pageof 5
Acta Obstetricia Et Gynecologica Scandinavica|October 1, 1995
Diagnosis of pelvic masses with transabdominal color Doppler, CA 125 and ultrasonographyM Franchi, P Beretta, F Ghezzi, et al.
Gynecologic Oncology|October 1, 1991
Salvage chemotherapy for ovarian cancer recurrence: weekly cisplatin in combination with epirubicin or etoposideF Zanaboni, G Scarfone, M Presti, et al.
Gynecologic Oncology|September 1, 1987
Tumor antigen CA 125 as a marker of ovarian epithelial carcinomaF Zanaboni, F Vergadoro, M Presti, et al.
Obstetrics and Gynecology|June 11, 1999
Endometrial thickness in tamoxifen-treated patients: an independent predictor of endometrial diseaseM Franchi, F Ghezzi, N Donadello, et al.
Obstetrics and Gynecology|November 5, 1997
Nonclosure of peritoneum at radical abdominal hysterectomy and pelvic node dissection: a randomized studyM Franchi, F Ghezzi, F Zanaboni, et al.
The Journal of the American Association of Gynecologic Laparoscopists|May 1, 1995
Management of adnexal masses by operative laparoscopyB van Herendael, P Beretta, T Slangen, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 19, 2000
A phase II study of high-dose epirubicin in ovarian cancer patients previously treated with cisplatin. EORTC Gynecological Cancer Cooperative GroupJ B Vermorken, A Kobierska, B Chevallier, et al.
European Journal of Cancer (Oxford, England : 1990)|January 30, 2004
'State of the art' of radical hysterectomy; current practice in European oncology centresJ B Trimbos, M Franchi, F Zanaboni, et al.
British Journal of Cancer|January 1, 1986
Evaluation of the interaction of mononuclear phagocytes with ovarian carcinoma cells in a colony assayG Peri, F Zanaboni, S Rossini, et al.
Tumori|February 29, 1988
Analysis of 309 cases after hydatidiform mole: different follow-up program according to biologic behaviorG Bolis, C Belloni, C Bonazzi, et al.
Pageof 5